logo

EbookBell.com

Most ebook files are in PDF format, so you can easily read them using various software such as Foxit Reader or directly on the Google Chrome browser.
Some ebook files are released by publishers in other formats such as .awz, .mobi, .epub, .fb2, etc. You may need to install specific software to read these formats on mobile/PC, such as Calibre.

Please read the tutorial at this link:  https://ebookbell.com/faq 


We offer FREE conversion to the popular formats you request; however, this may take some time. Therefore, right after payment, please email us, and we will try to provide the service as quickly as possible.


For some exceptional file formats or broken links (if any), please refrain from opening any disputes. Instead, email us first, and we will try to assist within a maximum of 6 hours.

EbookBell Team

Breast Cancer Metastasis And Drug Resistance Challenges And Progress 2nd Ed 2019 Aamir Ahmad

  • SKU: BELL-10797166
Breast Cancer Metastasis And Drug Resistance Challenges And Progress 2nd Ed 2019 Aamir Ahmad
$ 31.00 $ 45.00 (-31%)

4.3

88 reviews

Breast Cancer Metastasis And Drug Resistance Challenges And Progress 2nd Ed 2019 Aamir Ahmad instant download after payment.

Publisher: Springer International Publishing
File Extension: PDF
File size: 9.29 MB
Author: Aamir Ahmad
ISBN: 9783030203009, 9783030203016, 303020300X, 3030203018
Language: English
Year: 2019
Edition: 2nd ed. 2019

Product desciption

Breast Cancer Metastasis And Drug Resistance Challenges And Progress 2nd Ed 2019 Aamir Ahmad by Aamir Ahmad 9783030203009, 9783030203016, 303020300X, 3030203018 instant download after payment.

Resistance to therapies, both targeted and systemic, and metastases to distant organs are the underlying causes of breast cancer-associated mortality. The second edition of Breast Cancer Metastasis and Drug Resistance brings together some of the leading experts to comprehensively understand breast cancer: the factors that make it lethal, and current research and clinical progress. This volume covers the following core topics: basic understanding of breast cancer (statistics, epidemiology, racial disparity and heterogeneity), metastasis and drug resistance (bone metastasis, trastuzumab resistance, tamoxifen resistance and novel therapeutic targets, including non-coding RNAs, inflammatory cytokines, cancer stem cells, ubiquitin ligases, tumor microenvironment and signaling pathways such as TRAIL, JAK-STAT and mTOR) and recent developments in the field (epigenetic regulation, microRNAs-mediated regulation, novel therapies and the clinically relevant 3D models). Experts also discuss the advances in laboratory research along with their translational and clinical implications with an overarching goal to improve the diagnosis and prognosis, particularly that of breast cancer patients with advanced disease.

Related Products